Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 17539723)

Published in J Periodontol on June 01, 2007

Authors

Jill M Kramer1, Sarah L Gaffen

Author Affiliations

1: Department of Oral Biology, School of Dental Medicine, State University of New York at Buffalo, Buffalo, NY 14212, USA.

Articles citing this

Structure and signalling in the IL-17 receptor family. Nat Rev Immunol (2009) 6.38

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55

Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol (2011) 3.04

An overview of IL-17 function and signaling. Cytokine (2008) 2.38

A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res (2008) 2.05

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther (2008) 1.68

In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol (2008) 1.63

The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun (2008) 1.35

Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One (2009) 1.25

Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One (2012) 1.19

CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res (2011) 1.07

Th17 cells and HIV infection. Curr Opin HIV AIDS (2010) 0.96

Comparative Evaluation of IFNγ, IL4 and IL17 Cytokines in Healthy Gingiva and Moderate to Advanced Chronic Periodontitis. Dent Res J (Isfahan) (2010) 0.95

Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One (2014) 0.94

Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology (2008) 0.91

DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am J Respir Cell Mol Biol (2014) 0.91

RANKL expression in periodontal disease: where does RANKL come from? Biomed Res Int (2014) 0.90

Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nat Commun (2013) 0.89

Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. Mol Oral Microbiol (2015) 0.87

IL-17 receptor A signaling is protective in infection-stimulated periapical bone destruction. J Immunol (2013) 0.86

Constitutive expression of TNF-related activation-induced cytokine (TRANCE)/receptor activating NF-κB ligand (RANK)-L by rat plasmacytoid dendritic cells. PLoS One (2012) 0.85

Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC Immunol (2008) 0.81

T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetes. Cell Res (2011) 0.80

Activation and resolution of periodontal inflammation and its systemic impact. Periodontol 2000 (2015) 0.79

Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management? Open Access Rheumatol (2010) 0.79

Upregulation of IL-17A/F from human lung tissue explants with cigarette smoke exposure: implications for COPD. Respir Res (2014) 0.78

Non-inflammatory destructive periodontal disease: a clinical, microbiological, immunological and genetic investigation. J Appl Oral Sci (2012) 0.78

Interleukin-17 expression in murine pressure ulcer tissues. Exp Ther Med (2013) 0.77

Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis. Inflammation (2015) 0.77

Effects of curcumin on interleukin-23 and interleukin-17 expression in rat retina after retinal ischemia-reperfusion injury. Int J Clin Exp Pathol (2015) 0.75

GAKG-RGEKG an Epitope That Provokes Immune Cross-Reactivity between Prevotella sp. and Human Collagen: Evidence of Molecular Mimicry in Chronic Periodontitis. Autoimmune Dis (2016) 0.75

"What is there in a name?": A literature review on chronic and aggressive periodontitis. J Indian Soc Periodontol (2011) 0.75

Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease. Mediators Inflamm (2016) 0.75

Apical periodontitis and periodontal disease increase serum IL-17 levels in normoglycemic and diabetic rats. Clin Oral Investig (2014) 0.75

Articles by these authors

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol (2007) 10.71

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51

Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41

Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity (2009) 3.33

Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol (2004) 2.73

Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem (2006) 2.65

An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood (2007) 2.26

Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine (2008) 2.19

Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol (2004) 2.03

CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity (2011) 2.00

Th17 cells in immunity to Candida albicans. Cell Host Microbe (2012) 1.97

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol (2004) 1.96

Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci U S A (2007) 1.85

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem (2004) 1.77

IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol (2008) 1.73

IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol (2010) 1.69

NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One (2010) 1.69

1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol (2011) 1.67

Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci (2008) 1.60

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal (2009) 1.57

Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect (2010) 1.38

Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol (2009) 1.38

The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun (2008) 1.35

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res Ther (2012) 1.33

The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Invest (2004) 1.31

Evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol (2006) 1.29

IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev (2010) 1.23

The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal (2013) 1.16

IL-17RC: a partner in IL-17 signaling and beyond. Semin Immunopathol (2009) 1.14

Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells (2005) 1.13

Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol (2014) 1.13

Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. J Immunol (2007) 1.05

CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation. J Biol Chem (2007) 1.02

SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction. J Biol Chem (2010) 1.02

Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol (2009) 1.01

A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol (2009) 0.98

IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors. Cytokine (2013) 0.94

Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun (2013) 0.91

TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J Immunol (2011) 0.91

The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect Immun (2013) 0.90

Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. J Biol Chem (2008) 0.89

Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol (2014) 0.87

The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. PLoS One (2013) 0.86

Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit. J Biol Chem (2003) 0.84

IL-17 signaling and A20: a balancing act. Cell Cycle (2013) 0.79

Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses. Arthritis Res Ther (2014) 0.79

Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study. Clin Orthop Relat Res (2012) 0.77

Animal models for candidiasis. Curr Protoc Immunol (2014) 0.77

A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis. Infect Immun (2013) 0.76

Correction: Role of Neutrophils in IL-17-Dependent Immunity to Mucosal Candidiasis. J Immunol (2015) 0.75